-+ 0.00%
-+ 0.00%
-+ 0.00%

Noble Capital Markets Reiterates Outperform on Tonix Pharmaceuticals, Maintains $70 Price Target

Benzinga·03/20/2025 16:17:04
Listen to the news
Noble Capital Markets analyst Robert LeBoyer reiterates Tonix Pharmaceuticals (NASDAQ:TNXP) with a Outperform and maintains $70 price target.